APA

Gabay C., Burmester G. R., Strand V., Msihid J., Zilberstein M., Kimura T., van Hoogstraten H., Boklage S. H., Sadeh J., Graham N. M. H. & Boyapati A. (20210111). Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. : Arthritis research & therapy.

Chicago

Gabay Cem, Burmester Gerd R, Strand Vibeke, Msihid Jérôme, Zilberstein Moshe, Kimura Toshio, van Hoogstraten Hubert, Boklage Susan H, Sadeh Jonathan, Graham Neil M H and Boyapati Anita. 20210111. Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. : Arthritis research & therapy.

Harvard

Gabay C., Burmester G. R., Strand V., Msihid J., Zilberstein M., Kimura T., van Hoogstraten H., Boklage S. H., Sadeh J., Graham N. M. H. and Boyapati A. (20210111). Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. : Arthritis research & therapy.

MLA

Gabay Cem, Burmester Gerd R, Strand Vibeke, Msihid Jérôme, Zilberstein Moshe, Kimura Toshio, van Hoogstraten Hubert, Boklage Susan H, Sadeh Jonathan, Graham Neil M H and Boyapati Anita. Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. : Arthritis research & therapy. 20210111.